AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hoth Therapeutics, Inc. Director's Dealing 2019

Feb 15, 2019

34935_dirs_2019-02-15_5f181cda-bae7-4ed2-b908-b756c9bc7e3a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2019-02-14

Reporting Person: RICE KENNETH L JR (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	50000	Direct
Common Stock	726943	Indirect

Footnotes

F1: The securities are owned by Chelexa Biosciences, Inc. ("Chelexa"). Kenneth Rice is the Executive Chairman of Chelexa and in such capacity has voting and dispositive power of the securities held by such entity.